Longjin pharmaceutical co.
002750
80.66
0
中
EN
LINK
NMPA
MUYA AGRI-TECH
LONGJIN BIO-TECH
Shanghai Rouyishi BIO-TECH
YUNNAN MPA
About Longjin
Product & business
Science & Technology
News
Careers
Investors
Longjin Profile
Longjin History
Longjin's Mission &Vision
Longjin's Core Vlues
Responsibilities
Recognitions
Founder's Message
Medicines
HEMP
Natural Plant Extracts
Prospective Study
R&D Achievements
Smart Manufacturing
Whole Industry Chain
Notifications
Company News
LONGJIN IN Media
Longjin Culture
Grow With Us
Work At Longjin
Job Openings
Governance
Development Strategy
STOCK INFORMATION
Investor Services
Investors
Governance
Development Strategy
STOCK INFORMATION
Investor Services
关于深圳证券交易所《关于对昆明龙津药业股份有限公司2019年年报的问询函》的回复公告
关于深圳证券交易所《关于对昆明龙津药业股份有限公司2019年年报的问询函》的回复公告.pdf
PREV：
2020年半年度业绩预告
NEXT：
关于股东股份减持计划的进展公告
